Aspira Pathlab sets 53rd AGM for September 25, 2026
- Aspira Pathlab schedules 53rd AGM for September 25, 2026
- Meeting will be conducted via video conferencing at 2:00 pm
- FY26 annual report filed with BSE on August 31, 2026
- Physical dispatch letters sent to non-email registered members

*this image is generated using AI for illustrative purposes only.
Aspira Pathlab & Diagnostics Limited has scheduled its 53rd Annual General Meeting for September 25, 2026. The meeting will be held via video conferencing at 2:00 pm.
The Aspira Pathlab filed its annual report for FY26 with the Bombay Stock Exchange on August 31, 2026. The filing complies with Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Dispatch Details
On September 1, 2026, the company notified BSE Limited under Regulation 36(1)(b) of the SEBI LODR Regulations. It confirmed dispatching letters with web-links to access the Annual Report 2025-26 to members who have not registered email addresses.
Members who have registered emails received the documents directly. Those without registered emails received letters containing the exact path to view the report online. The cut-off date for email registration was August 28, 2026.
| Document | Status |
|---|---|
| Annual Report FY26 | Submitted |
| 53rd AGM Notice | Enclosed |
| Submission Date | August 31, 2026 |
| Dispatch Intimation | September 1, 2026 |
| Exchange | BSE Limited |
The documents are available on the company's official website. Neetu Maurya, Company Secretary and Compliance Officer, signed both the submission letter and the dispatch intimation.
Historical Stock Returns for Aspira Pathlab
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.02% | +18.69% | +47.31% | +140.30% | +112.84% | +81.56% |
What key financial metrics or strategic initiatives will be highlighted in Aspira Pathlab's FY26 annual report?
How might the outcomes of the 53rd AGM influence investor confidence and stock performance in the short term?
Are there any proposed dividend declarations or share buyback plans expected to be discussed at the upcoming meeting?


































